I am the one who received an email from Jonnie Williams Jr. after I enquired about the status of the supplement. (I tried to post it several times on the "clown board." It was either not allowed or was deleted.) Anyway, Mr. Williams states that the evaluation of supplement will be done by the end of this year. He did not say that a decision would be made about reintroducing it or not. He goes on to state the ongoing plans for the drug version.
I do not have any information regarding the availability of Anatabloc or an effort to return the product to market at this time. Rock Creek Pharmaceuticals Inc., has voluntarily suspended all sales of Anatabloc in August 2014, pending a internal review and analysis of its supplement business, which is expected to be completed by year end 2014. The Company is pursuing a clinical development program both in the US and in the United Kingdom. In the UK a Clinical Trial Application (CTA) is currently anticipated to be filed within the next four months. The Company has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration, which is on clinical hold pending additional data for the Agency to review. Concurrently we are advancing our lead compound as a drug into human clinical trials. Please check rockcreekpharmaceuticals.com <http://rockcreekpharmaceuticals.com/> for updates on availability of Anatabloc, or for additional information on the pharmaceutical program.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.